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Background: Interspinous distraction devices (IPDD) are indicated as stand-alone devices for the treatment of
spinal stenosis. The purpose of this study is to evaluate the results of patients undergoing surgery for spinal stenosis
with a combination of unilateral microdecompression and interspinous distraction device insertion.
Methods: This is a prospective clinical and radiological study of minimum 2 years follow-up. Twenty-two patients
(average age 64.5 years) with low-back pain and unilateral sciatica underwent decompressive surgery for lumbar
spinal stenosis. Visual Analogue Scale, Oswestry Disability Index and walking capacity plus radiologic measurements
of posterior disc height of the involved level and lumbar lordosis Cobb angle were documented both
preoperatively and postoperatively. One-sided posterior subarticular and foraminal decompression was conducted
followed by dynamic stabilization of the diseased level with an IPDD (X-STOP).
Results: The average follow-up time was 27.4 months. Visual Analogue Scale and Oswestry Disability Index
improved statistically significantly (p < 0.001) in the last follow-up exam. Also, the walking distance increased in all
patients but two. Posterior intervertebral disc height of the diseased level widened average 1.8 mm in the
postoperative radiograph compared to the preoperative. No major complication, including implant failure or
spinous process breakage, has been observed.
Conclusions: The described surgical technique using unilateral microdecompression and IPDD insertion is a
clinically effective and radiologically viable treatment method for symptoms of spinal stenosis resistant to
non-operative treatment.
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Lumbar spinal stenosis, refractory to nonoperative
treatment, has been traditionally treated with surgical
decompression achieving good and excellent results in
almost 80% of the cases [1]. In case of coexisting instability
or deformity or discogenic pain, fusion is added. However,
the immobilization of a spinal unit causes significant
functional changes to the patients in terms of spinal mo-
bility and symptomatology originating from adjacent seg-
ments [2].* Correspondence: aploumis@cc.uoi.gr
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reproduction in any medium, provided the or“Dynamic stabilization” spinal system is defined as the
system that alters favorably the biomechanics (move-
ment and load transmission) of a spinal motion segment,
without immobilization of the segment [3,4]. X-STOP is
an interspinous distraction device (IPDD) leading to in-
direct decompression by distraction [5] and disc unload-
ing [6]. It is indicated for patients older than 50 years
old with symptomatology of neurogenic claudication and
radiographic spinal stenosis up to two levels. It has been
suggested to be superior to laminectomy with or without
fusion for the above indications offering minimal surgical
trauma, avoidance of bone removal, immediate symptom
relief, fast recovery and rehabilitation and low complication
rate [7-9].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Medical Technologies, Inc. Alameda, CA and, lately,
by Medtronic Inc., Minneapolis, MN) device, an FDA
approved IPDD for patients with spinal stenosis [10],
in conjunction with minimally invasive lateral decom-
pression [11]. The purpose of this study is to present
the two-year follow-up results of surgical treatment for
patients with symptomatology of low-back pain and
unilateral sciatica due to spinal stenosis who did not
respond to nonoperative treatment. Our hypothesis is
that the combination of mini-open lateral decompression
and X-STOP insertion causes clinical improvement of
symptomatology without lordosis deterioration. Since no
control group was used, this mode of treatment is com-
pared to outcomes reported in studies using X-STOP
alone for lumbar spinal stenosis.
Methods
This a prospective study of 22 patients aged between
57–71 years (average 64.5 years) with unilateral sciatica
and low-back pain, in the form of neurogenic intermittent
claudication, who were treated by unilateral microdecom-
pression and X-STOP insertion in our hospital between
2006–2007. All patients consented to participate in the
study and ethics committee approval (no 11/2005 424
General Army Hospital, Thessaloniki, Greece) for the study
was obtained. The average T-score of bone density meas-
urement (DEXA) studies of the aforementioned patients
was −1.9. Patients’ activities involved mainly household
duties, gardening and daily walking but the disease signifi-
cantly affected their quality of life. All patients had plain
x-rays in standing position, dynamic radiographs in flexion
extension and MRI of the lumbar spine. No patient had
osteoporosis (T-score>−2.5), more than grade I spondylo-
listhesis, dynamic instability, motor deficit or severe lumbar
spinal stenosis (with or without kissing spinous processes)
as these were exclusion criteria in our study and containdi-
cations for X-STOP insertion. All patients had both central
and lateral spinal stenosis (subarticular, foraminal or both)
with disc degeneration at the involved levels.
The degree of spinal stenosis, according to radiologist
reading of the MRI, was mild to moderate. For central
stenosis, dural sac cross sectional area had to be between
100 and 130mm2 in the central canal area of transverse
MRI. Less than 100mm2 was considered severe stenosis
and these cases were excluded [12]. Mild to moderate
subarticular stenosis was defined as contact or deviation
of nerve root in the transverse cut MRI but cases with
root deformation were excluded [13]. Finally, cases with
foraminal stenosis were included if the epidural fat was
shown to be disappearing only partially in the sagittal
plane MRI [14].
In all cases pathology was found at L4-L5 level except
for four patients with stenosis both at L3-L4 and L4-L5levels. Initially nonoperative treatment for at least 3
months was applied for all patients including non-
steroidal anti-inflammatories, physical therapy, bracing
and transforaminal epidural steroid injections/selective
nerve root injections. When nonoperative treatment did
not alleviate their symptoms, surgical treatment was
performed. Microdecompression of the subarticular and
foraminal stenosis was based on the responses from
selective nerve root injections with anesthetic and steroids.
The Oswestry Disability Index (ODI) and the Visual
Analogue Scale (VAS) (for low-back pain and leg pain
separately) scores were documented preoperatively, at
the third week, six months and first year postoperatively
and at the last follow-up. Self-rated walking distance
preoperatively and after surgery at last follow up as well
as satisfaction regarding overall result of back operation,
according to questions of Zurich Questionnaire, were
evaluated [15].
Also, segmental lordosis of the involved levels and
lumbar lordosis (upper plate of L1 to upper plate of S1)
were measured by the Cobb angle in standing x-rays
both preoperatively and at the last follow-up. Finally,
radiographic posterior disc height of the involved levels
was measured preoperatively and at the last follow-up.
Radiographic manual measurements were done twice by
the first two authors (AP, PC) and the average was
recorded.
Statistical analysis both for the functional and radio-
graphic results was performed with the use SSPS 10.0. The
comparison was calculated with Student’s paired t-test.
Statistical significance was considered when p < 0.05.
Surgical technique
Under general anesthesia and prone position on a radio-
lucent table with padded support at the level of the iliac
crests and sternum, slight flexion of hips and knees
was preserved so that the subjects lie in a less lordotic
position. After an appropriately small skin incision
(approximately 4 centimeters), under fluoroscopic control,
and subcutaneous tissue incision, the dissection went
through the dorsolumbar fascia approximately 5–10 mm
lateral to the midline towards the symptomatic side, pre-
serving the supraspinous ligamentous attachment to the
fascia. The multifidus was detached from the symptomatic
side of the spinous processes and laminar attachments.
Retractors were placed to keep the wound open and were
being loosened regularly to avoid damage to the retracted
muscles. The ligamentum flavum was detached with a freer
elevator and then completely resected. The superior and
inferior laminae were only partially resected. Decompres-
sion of both exiting and transversing nerve roots at that
level were performed under microscope magnification.
Partial facetectomies (mainly undercutting the superior
facet) and foraminal decompressions were carried out with
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lengths and/or a power drill. The adequacy of decompres-
sion was checked with foraminal probes. No removal of
the central portion of laminae and no discectomy were
performed.
Next, the fascia was split longitudinally also to the other,
non-decompression, side of midline and multifidus is
detached only next to the interspinous area. It was of para-
mount importance for the stability of the segment to keep
the supraspinous and part of the interspinous ligaments
intact [16]. A small and, then, a larger blunt curved dilator
were inserted across the interspinous space abutting the
posterior border of the facet joints at the most anterior
margin of the interspinous space. After the larger dilator
was removed, a sizing distraction instrument is inserted.
The correct implant size was indicated on the sizing
instrument by tightening the supraspinous ligament in
distraction. An appropriately sized X-STOP device was
inserted between the spinous processes until it was flush
with the right side of the spinous processes and as much
anteriorly as possible in the interlaminar space. The screw
hole for the universal wing on the left side was visualized
and the universal wing screw was engaged. The two wings
were approximated toward the midline and the left-sided
universal wing screw was secured with a torque-limiting
hexagonal screwdriver. Anteroposterior and lateral fluor-
oscopy views were taken to verify the proper position.
After completion of both thorough decompression and
X-STOP insertion, the dorsolumbar fascia was sutured
over a suction drain.
Results
The follow-up period ranged from 24 to 36 months and
averaged 27.4 months. All patients were able to return
to their daily activities within six weeks postoperatively.
Both ODI and VAS low-back and leg pain scores
improved significantly postoperatively (p < 0.001) and
this improvement deteriorated slightly (p > 0.05) in the
last follow-up (Table 1). Using a 25-point improvement
from baseline Oswestry Disability Index score as a suc-
cess criterion, 20 out of 22 patients (91%) had success-
ful outcomes.Table 1 Clinical and radiographic measurements (mean
(SD))
Preoperatively Last follow-up p-value
ODI 50.7 (4.4) 19.9 (3.7) < 0.001
VAS (back pain) 4.5 (1.0) 2.5 (0.7) < 0.001
VAS (leg pain) 7.5 (0.6) 2.6 (0.8) < 0.001
Posterior intervertebral
height (mm)
5.9 (1.6) 7.7 (2.2) < 0.001
Lumbar lordosis (°) 52.8 (4.5) 53.4 (4.4) non-significant
Segmental lordosis (°) 5.7 (3.5) 3.3 (2.5) < 0.001When the self-assessment evaluation of Zurich Ques-
tionnaire was used for the satisfaction from surgery, only
two patients responded somewhat satisfied while the rest
twenty patients (90.9%) declared very satisfied. In terms
of walking distance, none deteriorated, six patients
improved one grade and four improved two grades
(Figure 1).
The interspinous implants used were mainly 10mm
and 12mm height size and 8mm implant was inserted
only in two levels.
Radiographic analysis of standing x-rays of the lumbar
spine showed a mean increase of 1.8 mm of the posterior
intervertebral disc height of the operated levels and the
postoperative height was significantly larger than preopera-
tively (p < 0.001) (Figure 2). Specifically, there was an in-
crease of posterior disc height after implant insertion in 23
out of 26 disc spaces. Also, the mean segmental lordosis
was significantly decreased (p < 0.001) postoperatively
compared to preoperative respective value. However, the
mean lumbar lordosis did not show statistical significant
change (p > 0.05) in the postoperative period (Table 1).
In a pilot study of our first patients, the postoperative
MRI showed the expansion of the space available for the
sac following the unilateral decompression (Figure 3).
There were no major complications in our series. No
obvious by plain x-rays spinous process fracture was
detected; however there was one asymptomatic case of
gradual displacement of the superior to the implant
spinous process which suggested a possible fracture.
Two patients with radiculitis originating from the level
above the decompressed level were treated successfully
with anti-inflammatory medication five months post-
operatively. In another two cases, the X-STOP device
was not inserted anteriorly enough in the interspinous
space but this did not cause symptoms.
Discussion
The rationale for this study was to evaluate if the combin-
ation of direct unilateral decompression and the indirect
decompression with an IPDD device (X-STOP) was effect-
ive for the patients with neurogenic claudication due to
spinal stenosis and, also, to compare our results with his-
torical controls of other studies using only X-STOP device.
This study intends to show the validity of the presented
method of direct and indirect decompression of neural
elements and not to show the superiority to other estab-
lished treatment methods (stand-alone decompression,
stand-alone X-STOP insertion).
The first IPDD implanted in patients with neurogenic
intermittent claudicaton (NIC) due to spinal stenosis
was the X-STOP (first FDA approved) [3]. X-STOP in-
sertion with blunt instruments only does not violate the
supraspinous/interspinous complex and can be implanted
under local anesthesia [17].
Figure 1 Chart showing preoperative and postoperative walking capacity of patients according to Zurich Questionnaire.
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the canal and foramen [18-20]. As Cabraja et al.
described [5], insertion of an interspinous device can
decrease the facet joint back pain. Similarly, patients in
our study showed significant less axial low-back pain
postoperatively than preoperativiely. However, the main
benefit was the decrease of leg pain in the form of
neurogenic caludication.
In cases with lateral spinal stenosis including subarti-
cular and foraminal nerve root impingement, indirect
decompression by X-STOP insertion only may not be as
beneficial when there is long-term inflammation in the
area. It is advantageous that a direct decompression isFigure 2 Preoperative (A) and postoperative (B) lateral lumbar radiog
lateral decompression showing increase of posterior intervertebral diperformed in lateral subarticular and foraminal area in
order to free nerve roots from adhesions due to the
chronic inflammation tissue. This combination of direct
(mini-open) and indirect (by X-STOP insertion) decom-
pression was performed in our patients. In a biomechanical
cadaveric study of X-STOP device by Fuchs et al. [21],
unilateral facetectomies did not lead to added instability of
the spinal unit with interspinous devices and in contrast to
the instability caused by bilateral facetectomies.
The addition of X-STOP device can distract the
intervertebral space and preserve the nerve-occupying
space without sacrificing the mobility of the motion
segment [7-9].raph of a patient treated with x-stop insertion and left direct
sc height and preservation of lumbar lordosis.
Figure 3 Preoperative (A) and postoperative (B) transverse T2 MRI images at the stenotic level of the same patient shown in Figure 2.
Unilateral microdecompression and X-STOP insertion was performed. The postoperative increase of the space available for the sac is shown.
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patients with spinal stenosis and neurogenic claudica-
tion treated surgically with X-STOP only without direct
decompression. The patients of our study achieved
similar improvement in functional scores and higher
satisfaction (except Kuchta study [22]) in the second
postoperative year compared to patients treated with
X-STOP only.
In a randomized controlled, prospective, multicenter
trial outcome study, patients suffering from neurogenic
intermittent claudication treated with X-STOP were
compared to outcomes of similargroup patients treated
conservatively [9,10]. These class I clinical data included
patients with mild to moderate spinal stenosis. X-STOP
was found significantly more effective compared to
conservative treatment after two years follow up. The
X-STOP patients group had significant improvement of
clinical symptoms and function compared with epidural
steroid injections treated patient group. Successful outcome
in our unicenter study group, even though in smaller
numbers, reached to 91% of the patients.Table 2 Bibliographic analysis of clinical outcome studies wit




Kondrashov et al (JSDT 2006) [14] 18 x-stop only 51
Shidiqui et al (Spine 2007) [22] 24 x-stop only 12
Zucherman et al (Spine 2005) [8] 93 x-stop only 24
Brussee et al (Eur Spine J 2008) [23] 65 x-stop only 12
Kuchta et al (Eur Spine J 2009) [20] 175 x-stop only 24
Ploumis et al 22 x-stop plus
decompression
27.4Lee et al [23]. experience similar satisfaction rates with
Zucherman et al [10],. but the individuals in his study
found only 40% improvement in severity of symptoms.
29% of the patients in Siddiqui et al. study [24] lost
beneficial effect of X-STOP implantation after the third
month and had to have epidural steroid injection in a
year’s time after the operation. It was presumed that
because of the position of the device, bony indentations
occur at the contact area of the spinous process and with
time this led to reduction of the initial distraction. Kim
et al. reported postoperative fractures of the spinous
processes diagnosed by CT in 22% of patients with
IPDD insertion but only half of them were symptomatic
[25]. All of our patients had well seated implants in the
anterior interspinous area, except two who did not need
revision.
In our study elective microdecompression surgery
was combined with X-STOP insertion. The patients
included were suffering from mild to moderate severity
central and unilateral lumbar spinal stenosis. Conservative




of ZCQ (% of pts)
29 (ODI) not reported
11 (ODI) 71
45.4% (ZCQ symptom severity domain) 73.1
48.4% (ZCQ walking ability) 74.2
12 (ODI) not reported
30 (ODI) 90.9
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eral laminotomy, subarticular and foraminal (undercutting)
decompression with an effort to avoid complete facetec-
tomies. After microdecompression, X-STOP was applied at
the diseased levels. All the patients were evaluated before
surgery and postoperatively at 3 weeks, 6 months, 1 year
and 2 years follow-up. Our outcome tools were VAS, ODI
and certain questions on walking capacity and patient sat-
isfaction from Zurich Questionnaire, all of which improved
significantly. Posterior disc height of the involved level and
Cobb angle were documented pre- and postoperatively.
Lumbar lordotic Cobb angle did not change statistically
significantly even though segmental lordosis decreased.
This means that lordosis increased in the adjacent motion
segments to improve sagittal balance. In contrary to other
studies, posterior intervertebral disc height at the involved
levels increased in average 1.8 mm postoperatively
compared to preoperatively in accordance to results from
Sobottke et al [26]. No major complication, significant
blood loss, or slippage of device was detected.
The anatomic advantage of direct decompression of
neural tissues is obviously superior to indirect decom-
pression. The financial cost of adding an IPDD in a
microdecompression case may be exchanged by the last-
ing clinical improvement and the preservation of disc
height and lordosis.
Limitation to our study is the absence of a control
patient group. A prospective randomized study comparing
IPDD insertion only to IPDD insertion plus direct
decompression is under way. This study provides level
IV evidence and should be considered this way.
Conclusions
Direct lateral microdecompression in addition to indirect
decompression by an IPDD (X-STOP) insertion is a
clinically effective and radiologically viable treatment
option for patients with mild to moderate lumbar spinal
stenosis.
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